What is ELVN's market capitalization?

Enliven Therapeutics Inc. has a market capitalization of $2.32B.

Does ELVN pay a dividend?

Enliven Therapeutics Inc. does not currently pay a dividend, or dividend data is unavailable. Many growth-oriented companies reinvest profits rather than paying dividends.

What is ELVN's earnings per share (EPS)?

Enliven Therapeutics Inc.'s trailing twelve-month earnings per share (EPS) is -$1.83. EPS measures the portion of company profit allocated to each outstanding share of stock.

ELVN

NASDAQ

Enliven Therapeutics Inc.

Price unavailable — configure POLYGON_API_KEY

Overview Earnings Dividends

Key Statistics

Market Cap$2.32B

P/E RatioN/A

Div. Yield—

EPS (TTM)-$1.83

52W High$40.62

52W Low$13.30

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

Employees60

Price Performance

1 Week0.00%

3 Month+155.29%

1 Year+93.86%

FinancialsAnnual · QuiverQuant

Revenue$0

Assets$271.87M

Liabilities$25.96M

Net Income$71.58M loss

About

Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer treatment and addressing other serious diseases through its proprietary therapeutic platforms. The firm possesses a promising pipeline of cutting-edge drug candidates, developed using advanced biopharmaceutical technologies, with the goal of enhancing patient outcomes and overall quality of life. With a steadfast commitment to scientific excellence and the pursuit of solutions for significant unmet medical needs in oncology, Enliven is strategically positioned to generate shareholder value while contributing positively to the healthcare landscape.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account

Analyze ELVN with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.